Susquehanna International Group, LLP Avrobio, Inc. Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$1.15 - $1.48 $39,709 - $51,104	34,530 New	34,530 $44,000
Q1 2023 May 16, 2023	BUY	$0.76 - $1.82 $18,550 - $44,424	24,409 New	24,409 $24,000
Q2 2022 Aug 15, 2022	BUY	$0.75 - $1.33 $12,954 - $22,971	17,272 New	17,272 $16,000
Q1 2022 May 16, 2022	SELL	$1.29 - $4.04 $28,056 - $87,865	-21,749 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.45 - $6.05 $33,226 - $58,267	9,631 Added 79.48%	21,749 $84,000
Q3 2021 Nov 15, 2021	SELL	$5.53 - $9.28 $166,945 - $280,153	-30,189 Reduced 71.36%	12,118 $68,000
Q2 2021 Aug 11, 2021	BUY	$7.84 - $12.6 $109,085 - $175,316	13,914 Added 49.01%	42,307 $376,000
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $98,243 - $179,895	9,321 Added 48.87%	28,393 $360,000
Q4 2020 Feb 16, 2021	BUY	$12.79 - $17.1 $243,930 - $326,131	19,072 New	19,072 $266,000
Q2 2020 Aug 14, 2020	SELL	$12.19 - $22.96 $160,725 - $302,727	-13,185 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $132,904 - $358,763	13,185 New	13,185 $205,000
Q4 2019 Feb 14, 2020	SELL	$13.05 - $21.88 $146,199 - $245,121	-11,203 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $158,186 - $262,598	11,203 New	11,203 $158,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.